Scotiabank Begins Coverage on Apellis Pharmaceuticals (NASDAQ:APLS)
Stock analysts at Scotiabank assumed coverage on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) in a note issued to investors on Wednesday, Briefing.com reports. The brokerage set a “sector outperform” rating on the stock. Several other analysts have also recently issued reports on the company. HC Wainwright dropped their target price on Apellis […]
More Stories
SPACE ID Price Reaches $0.38 (ID)
SPACE ID (ID) traded down 1.5% against the US dollar during the twenty-four hour period ending at 16:00 PM Eastern...
Orbler 24-Hour Trading Volume Tops $65,821.38 (ORBR)
Orbler (ORBR) traded down 7.9% against the US dollar during the one day period ending at 16:00 PM E.T. on...
Blur (BLUR) Self Reported Market Capitalization Tops $19.58 Million
Blur (BLUR) traded 3.7% lower against the dollar during the 1-day period ending at 16:00 PM E.T. on October 16th....
Texas Instruments Incorporated (NASDAQ:TXN) Shares Bought by McKinley Carter Wealth Services Inc.
McKinley Carter Wealth Services Inc. increased its position in Texas Instruments Incorporated (NASDAQ:TXN – Free Report) by 2.2% during the...
Meta Platforms, Inc. (NASDAQ:META) Shares Purchased by Petredis Investment Advisors LLC
Petredis Investment Advisors LLC grew its holdings in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 1.4% during...
Dover Advisors LLC Boosts Holdings in Meta Platforms, Inc. (NASDAQ:META)
Dover Advisors LLC raised its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 7.6% in the...